Analysis of an oligonucleotide N3′→P5′ phosphoramidate/phosphorothioate chimera with capillary gel electrophoresis

被引:4
|
作者
Dedionisio, LA [1 ]
Raible, AM [1 ]
Nelson, JS [1 ]
机构
[1] Lynx Therapeut Inc, Hayward, CA 94545 USA
关键词
N3 '-> P5 ' phosphoramidate; phosphorothioate; chimeric oligonucleotide; gapmer;
D O I
10.1002/elps.1150191623
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
N3'-->P5' phosphoramidate/phosphorothioate chimeric oligonucleotides (ODNs) are presently under investigation as potential antisense drugs. Within the field of antisense research, "second generation" chimeric ODNs have exhibited improved characteristics relative to oligonucleotides with uniformly modified backbones. The ODN of interest for this study consisted of a chemically synthesized 18-mer of mixed nucleotide base sequence: with a backbone consisting of eight central phosphorothioate linkages flanked by four N3'-->P5' phosphoramidate (amidate) linkages on the 5'-end and five amidate linkages ont he 3'-end. This chimera presents analytical challenges due to the central phosphorothioate region. Here, we present a capillary gel electrophoresis (CGE) method for the analysis of the above N3'-->P5' phosphoramidate/phosphorothioate chimera. CGE was used to analyze the product prior to its purification by reversed phase - high performance liquid chromatography (RP-HPLC), and each fraction collected from the purification was similarly analyzed. An internal standard was utilized to determine the relative mobility of our product, and polyacrylamide gel electrophoresis (PAGE) analysis was used to verify CGE results.
引用
收藏
页码:2935 / 2938
页数:4
相关论文
共 50 条
  • [1] The detection of oligonucleotide N3′→P5′ phosphoramidate RNA duplexes with capillary gel electrophoresis
    DeDionisio, L
    Raible, AM
    Gryaznov, SM
    ELECTROPHORESIS, 1998, 19 (8-9) : 1265 - 1269
  • [2] ANALYSIS OF A RIBONUCLEASE-H DIGESTION OF N3'-]P5' PHOSPHORAMIDATE RNA DUPLEXES BY CAPILLARY GEL-ELECTROPHORESIS
    DEDIONISIO, L
    GRYAZNOV, SM
    JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 669 (01): : 125 - 131
  • [3] A new approach to oligonucleotide N3′ → P5′ phosphoramidate building blocks
    Zielinska, Daria
    Pongracz, Krisztina
    Gryaznov, Sergei M.
    TETRAHEDRON LETTERS, 2006, 47 (26) : 4495 - 4499
  • [4] A new approach to oligonucleotide N3′→P5′ phosphoramidate building blocks
    Zielinska, D
    Pongracz, K
    Gryaznov, S
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2005, 24 (5-7): : 1063 - 1067
  • [5] OLIGONUCLEOTIDE N3'-]P5' PHOSPHORAMIDATES
    GRYAZNOV, SM
    LLOYD, DH
    CHEN, JK
    SCHULZ, RG
    DEDIONISIO, LA
    RATMEYER, L
    WILSON, WD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (13) : 5798 - 5802
  • [6] Comparison of binding of N3′→P5′ phosphoramidate and phosphorothioate oligonucleotides to cell surface proteins of cultured cells
    Hawley, P
    Nelson, JS
    Fearon, KL
    Zon, G
    Gibson, I
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1999, 9 (01): : 61 - 69
  • [7] An improved method for the synthesis of N3'->P5' phosphoramidate oligonucleotides
    McCurdy, SN
    Nelson, JS
    Hirschbein, BL
    Fearon, KL
    TETRAHEDRON LETTERS, 1997, 38 (02) : 207 - 210
  • [8] Oligonucleotide N3′ → P5′ thio-phosphoramidate telomerase template antagonists as potential anticancer agents
    Gryaznov, S
    Asai, A
    Oshima, Y
    Yamamoto, Y
    Pongracz, K
    Pruzan, R
    Wunder, E
    Piatyszek, M
    Li, SH
    Chin, A
    Harley, C
    Akinaga, S
    Yamashita, Y
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2003, 22 (5-8): : 577 - 581
  • [9] Oligonucleotide N3'->P5' phosphoramidates as antisense agents
    Gryaznov, S
    Skorski, T
    Cucco, C
    NieborowskaSkorska, M
    Chiu, CY
    Lloyd, D
    Chen, JK
    Koziolkiewicz, M
    Calabretta, B
    NUCLEIC ACIDS RESEARCH, 1996, 24 (08) : 1508 - 1514
  • [10] Oligonucleotide N3′→P5′ thiophosphoramidates:: synthesis and properties
    Pongracz, K
    Gryaznov, S
    TETRAHEDRON LETTERS, 1999, 40 (43) : 7661 - 7664